Erythropoietin counteracts breast cancer treatment with herceptin

Links shared publicly online about this topic.

724
total visits

Erythropoietin counteracts breast cancer treatment with herceptin

Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.

View full resource at physorg.com

Tags: Anemia Medication, Breast Cancer, Women's Health, Procrit, Eprex, Epogen, NeoRecormon, Epogin

Most Recently Shared on November 15, 2010 at 9:50 pm By:

FightCancer

Erythropoietin counteracts breast cancer treatment with herceptin http://bit.ly/bsbAIO

2 years ago...

Retweet

Favorite

Erythropoietin Counteracts Breast Cancer Treatment with Herceptin

newswise.com — “Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.” View full resource at newswise.com